All the companies that we follow here at 24/7 Wall St. keep a list for their top institutional and retail clients of high-conviction stock picks. These are generally the companies they not only like on a longer term basis, but those stocks that usually have big upside to the assigned target price. Many firms on Wall Street recently have tweaked their lists to account for potential changes in the fourth quarter and for 2019, and one company has added an outstanding stock we feel could have outsized upside.
In a recent research note, the analysts at Jefferies make a big move by adding a top health care company to the firm’s well respected Franchise Picks list of stocks to Buy. We cover this new addition, and we also screened the list for the highest dividend paying stocks in the group.
Shares of Teladoc Health Inc. (NASDAQ: TDOC) were added to the list and, given the strength in the sector, the stock may be a great buy now. This innovative health care company offers a telehealth platform, delivering on-demand health care anytime, anywhere, through mobile devices, the internet, video and phone.
The company’s solution connects its members with its more than 3,000 board-certified physicians and behavioral health professionals treating a range of conditions and cases from acute diagnoses, such as upper respiratory infection, urinary tract infection and sinusitis to dermatological conditions, anxiety and smoking cessation. Teladoc Health serves over 7,500 employers, health plans, health systems and other entities. And these clients collectively purchased access to its solution for more than 20 million members.
The Jefferies team said this about Teladoc in its report:
We add Teladoc to the Franchise Pick list. The analysis of web and app data suggests that the roll out across CVS’ app and website is on track to contribute 200-210k ‘paid’ visits for Teladoc in 2019. This would represent a 7-9% increase in total visits, and the figure is likely conservative. He finds shares particularly attractive given the recent pullback and increased visibility toward 25%+ revenue growth. Teladoc is well positioned to benefit from the evolution of healthcare delivery.
Jefferies has a $95 price target on the stock, while the Wall Street consensus target is $87.72. The shares closed on Monday at $69.14, up over 3% on the day.
Below are the four top dividend-paying stocks on the Franchise List.
This stock has traded in a tight range all year and looks ready to break out. Boeing Co. (NYSE: BA) is the world’s leading aerospace company and the largest manufacturer of commercial jetliners and military aircraft combined.
The different segments in the company are: Commercial Airplanes; Boeing Defense, Space & Security and Boeing Capital, which provides financial solutions facilitating sale and delivery of Boeing commercial and military aircraft, satellites, and launch vehicles.
Boeing and Embraer signed a nonbinding memorandum of understanding to create a new strategic partnership for commercial aviation. The new joint venture is valued at $4.75 billion, which values Boeing’s 80% share at $3.8 billion.
Boeing shareholders are paid a 1.92% dividend. The Jefferies price objective for the shares is $410, and the consensus target price is $413.30. The stock closed Monday at $355.98 a share.